Neuronetics, Inc.
General ticker "STIM" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $121.4M (TTM average)
Neuronetics, Inc. follows the US Stock Market performance with the rate: 30.4%.
Estimated limits based on current volatility of 3.2%: low 1.88$, high 2.01$
Factors to consider:
- Total employees count: 658 (-8.1%) as of 2025
- US accounted for 97.9% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Failure to achieve profitability, Third-party risks, Inability to compete, Product development failure, Regulatory and compliance
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.91$, 2.96$]
- 2026-12-31 to 2027-12-31 estimated range: [0.84$, 2.68$]
Financial Metrics affecting the STIM estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: 12.78 < Shareholder equity ratio, % of 15.81 <= 25.20
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -5.72
- Positive: -1.23 < Investing cash flow per share per price, % of -0.85
- Positive: Interest expense per share per price, % of 8.95 <= 10.35
Short-term STIM quotes
Long-term STIM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $71.35MM | $74.89MM | $149.16MM |
| Operating Expenses | $101.90MM | $109.45MM | $180.59MM |
| Operating Income | $-30.55MM | $-34.56MM | $-31.44MM |
| Non-Operating Income | $0.36MM | $-9.18MM | $-7.70MM |
| Interest Expense | $5.42MM | $7.29MM | $8.41MM |
| R&D Expense | $9.52MM | $12.77MM | $6.58MM |
| Income(Loss) | $-30.19MM | $-43.74MM | $-39.13MM |
| Taxes | $0.00MM | $-0.01MM | $0.00MM |
| Net Income(Loss)* | $-30.19MM | $-43.71MM | $-39.00MM |
| Stockholders Equity | $34.19MM | $27.71MM | $22.38MM |
| Inventory | $8.09MM | $4.25MM | $4.33MM |
| Assets | $115.83MM | $140.90MM | $141.55MM |
| Operating Cash Flow | $-32.04MM | $-31.00MM | $-20.37MM |
| Capital expenditure | $2.37MM | $1.47MM | $0.80MM |
| Investing Cash Flow | $-1.32MM | $-2.41MM | $-0.80MM |
| Financing Cash Flow | $22.70MM | $-6.81MM | $35.85MM |
| Earnings Per Share** | $-1.05 | $-1.38 | $-0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.